ANUH PHARMA LTD has issued a public notice to shareholders regarding the opening of a special window for transfer and dematerialisation of physical shares. The announcement, published on April 17, 2026, in Financial Express (English) and Mumbai Lakshdeep (Marathi) editions, follows the SEBI Circular dated January 30, 2026.

Special Window Details

The special window facility addresses physical share transfer requests that were lodged prior to April 01, 2019, but remained unprocessed due to various deficiencies. According to the company's notice, this window is specifically available for requests that were rejected, returned, or not attended due to deficiencies in documents, process, or other reasons.

Eligibility Criteria

The company has provided a clear matrix to help investors understand their eligibility for the special window:

Eligible Cases:

• Fresh lodgement (not lodged before April 01, 2019) with original share certificates
• Previously lodged but rejected/returned requests with original certificates

Ineligible Cases:

• Previously lodged requests where original certificates are no longer with the investor
• Cases where shares were not lodged and original certificates are not available

Process and Requirements

Investors wishing to utilise this facility must contact the company's Registrar and Share Transfer Agent, Bigshare Services Private Limited. The registrar is located at Office No S6-2, 6th Floor, Pinnacle Business Park, Mahakali Caves Road, Andheri (East), Mumbai - 400093.

The notice emphasises that only requests accompanied by original share certificates along with transfer deeds and other supporting documents will be considered under the special window. This disclosure has been simultaneously uploaded on the company's website at www.anuhpharma.com for broader accessibility.

Regulatory Compliance

The initiative demonstrates ANUH PHARMA's commitment to regulatory compliance and shareholder service. The special window provides a valuable opportunity for eligible shareholders to complete their pending transfer and dematerialisation processes, ensuring their holdings are properly recorded in dematerialised form as per current market practices.

Anuh pharma Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI depositories regulations. The pharmaceutical company filed the mandatory certificate for the quarter ended 31st March, 2026, demonstrating its commitment to regulatory compliance.

Regulatory Filing Details

The company submitted the certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 to both BSE Limited and National Stock Exchange of India Limited on 07th April, 2026. Company Secretary & Compliance Officer Manan Vadhan signed the submission letter, ensuring proper authorization of the filing.

Certificate Confirmation

Bigshare Services Private Limited, serving as the company's Registrar & Share Transfer Agent, issued the confirmation certificate dated 04th April, 2026. The certificate specifically states that no dematerialisation requests for equity shares were received during the period from 01st January, 2026 to 31st March, 2026.

Stock Exchange Information

Anuh Pharma Limited maintains listings on both major Indian stock exchanges. The company trades on BSE Limited under scrip code 506260 and on National Stock Exchange of India Limited under the symbol ANUHPHR in the EQ series.

Company Operations

Anuh Pharma Limited operates with its registered office located at 3-A, Shivsagar Estate, North Wing, Dr. Annie Besant Road, Worli, Mumbai. The company maintains manufacturing facilities at E-17/3, E-17/4 & E-18, M.I.D.C., Tarapur, BOISAR, Dist. Palghar, reflecting its operational presence in Maharashtra's pharmaceutical hub.